- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07583615
Social Attention in ASD and TD Children
Dynamic Gaze Strategies in ASD Children During Social Interactions: An Eye-Tracking Investigation Under Intention-Congruent and -Incongruent Conditions
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Sichuan
-
Chengdu, Sichuan, China, 611731
- School of Foreign Languages, University of Electronic Science and Technology of China
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder. For TD group: Typically developing children without any developmental or neurological disorders.
Both groups: Normal or corrected-to-normal vision, no color vision deficiencies, and legal guardian provided written informed consent.
Exclusion Criteria:
- Failure to meet the study's group-specific screening cutoffs on the Social Responsiveness Scale (SRS) and Social Communication Questionnaire (SCQ) Known genetic syndromes, significant hearing loss, or uncorrectable visual impairment
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
|---|
|
Autism Spectrum Disorder (ASD) Group
|
|
Typically Developing (TD) Group
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of Total Fixation Duration on Human Faces during Entire Video
Tijdsspanne: During the full 27-second video presentation
|
Percentage of total fixation duration on human faces was calculated as (total fixation duration on all face areas of interest / total fixation duration on the entire video) × 100.
Fixation was defined as gaze maintained within a 1° visual angle for a minimum of 100 ms.
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Total Fixation Duration on Human Faces during Entire Video
Tijdsspanne: During the full 27-second video presentation
|
Total fixation duration (in milliseconds) on human faces, calculated as the sum of all fixation durations that fell within face areas of interest (AOIs).
This measure was compared between the ASD and TD groups.
|
During the full 27-second video presentation
|
|
Percentage of Total Fixation Duration on Human Faces During Phase 4 (Emotional Feedback) by Condition
Tijdsspanne: During seconds 22-27 of the video
|
Percentage of fixation duration on faces was calculated for the emotional feedback phase separately for Preference-congruent and Preference-incongruent trials.
The interaction between Group (ASD vs. TD) and Condition (Congruent vs. Incongruent) was examined.
Higher percentages indicate greater allocation of visual attention to faces during emotional feedback.
|
During seconds 22-27 of the video
|
|
Total Scanpath Length During Entire Video
Tijdsspanne: During the full 27-second video presentation
|
During the full 27-second video presentation
|
|
|
Number of Gaze Shifts Between Face and Object Areas of Interest
Tijdsspanne: During the full 27-second video presentation
|
The number of saccadic gaze shifts that cross between pre-defined face and object areas of interest (AOIs) was counted.
This was taken as an index of attentional switching between social and non-social information.
|
During the full 27-second video presentation
|
|
Mean Distance of Fixation Points from the Center of the Face Area of Interest
Tijdsspanne: During the full 27-second video presentation
|
For each fixation, the Euclidean distance (in degrees of visual angle) from its location to the centroid of the pre-defined face AOI was calculated.
The mean of these distances across all fixations was then computed.
Larger values indicate that gaze tended to fall farther from the faces, reflecting less attention to facial information.
|
During the full 27-second video presentation
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- UESTC-GazeLab-02
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .